Brachytherapy is a form of radiotherapy in which a closed radiation source is placed directly into or near to the area to be treated. It is commonly used as a successful treatment for breast, cervical, skin, and prostate cancers and is utilised to cure cancer tissues at precise areas. Brachytherapy, on the other hand, entails injecting a radioactive substance directly into or around the tumour. One of the most distinguishing features of brachytherapy is that it is administered in a specific area around the radiation source, reducing radiation exposure to healthy tissues.
Brachytherapy treatment courses can be completed faster than other radiotherapy procedures, reducing the risk of surviving cancer cells growing and dividing over the long periods between radiotherapy sessions. Two types of brachytherapy afterloaders are available on the market, depending on the technique: low dose rate (LDR) afterloader and high dosage rate (HDR) afterloader.
To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1952
Brachytherapy Afterloaders Market – Dynamics
The rising frequency of cancer among the global population is one of the primary factors driving the market for brachytherapy afterloaders. According to the World Health Organization (WHO) 2018 report, cancer was the second-leading cause of death worldwide in 2015, accounting for over 8.8 million deaths. Cancer is responsible for around one out of every six deaths worldwide. The same report showed that, most common causes of cancer death was lung cancer with around 1.69 million deaths followed by liver cancer with 788,000 deaths, colorectal 774,000 deaths, stomach 754,000 deaths, and breast cancer having 571,000 deaths.
The growing geriatric population around the world is another factor contributing to the rise in cancer incidence, as the elderly are more susceptible to the disease. Another aspect driving the market for brachytherapy afterloaders is its high growth rate. For example, according to United Nation 2017 report, the geriatric population in 2017 is expected to increase over double by 2050 and to over triple by 2100. These figures are expected to rise from 962 million globally in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100.
Furthermore, rising brachytherapy usage among cancer treatment centres is expected to enhance the market for brachytherapy afterloaders significantly in the near future. For example, iCAD Inc. launched the Xoft electronic brachytherapy system in 2017 at two of its California-based oncology sites, Sherman Oaks Radiation Therapy Center and Santa Clarita Radiation Therapy Center.
To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1952
Brachytherapy Afterloaders Market – Regional Insights
The global brachytherapy afterloaders market is divided into North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa, based on region. Because of the increasing acceptance of new revolutionary technologies and increased financing for cancer treatment research and development, North America dominates the global brachytherapy afterloaders market. For example, in 2013, Varian Medical Systems, Inc. awarded US$ 100,000, a second year renewal grant to The American Board of Radiology Foundation (ABRF), for the brachytherapy research work.
The brachytherapy afterloader market in Asia Pacific is predicted to develop significantly, owing to increased healthcare research and a growing senior population susceptible to cancer and related disorders. According to a 2017 United Nations estimate, 12 percent of Asia’s population is now 60 years old, with the proportion expected to rise to 24 percent by 2050.
Brachytherapy Afterloaders Market – Competitive Landscape
Elekta, Eckert & Zieglar BEBIG, and Varian Medical Systems, Inc. are among the major participants in the brachytherapy afterloaders market. To maintain their market position, market participants are employing a variety of techniques such as acquisitions, new product releases, acquisitions, and alliances. Proton Partners International Ltd., for example, purchased Elekta MR-linac sytems in April 2018.
Brachytherapy Afterloaders Market – Taxonomy
On the basis of technique, the global brachytherapy afterloaders market is segmented into:
- Low Dose Rate (LDR) Afterloaders
- High Dose Rate (HDR) Afterloaders
On the basis of application, the global brachytherapy afterloaders market is segmented into:
- Prostate Cancer
- Breast Cancer
- Cervical Cancer
On the basis of region, the global brachytherapy afterloaders market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
To Direct Purchase this Premium Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1952
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027